Evidence map›Paper›PMID 31420381›Full record

ArticleBMJ open2019

Patients' information needs and attitudes about post-treatment surveillance for colorectal cancer in the United States: a multi-perspective, mixed methods study.

Lisa M Lowenstein, Robert J Volk, Amanda Cuddy, Andrea P Hempstead, Y Nancy You, Katherine Van Loon, Stefanos Millas, Jeffrey A Meyerhardt, Patrick Gavin, George J Chang

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. The needs of colorectal cancer patients/survivors: A narrative review.Journal of education and health promotion · 2022
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Lisa M LowensteinDepartment of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA LMLowenstein@mdanderson.org.
Robert J VolkDepartment of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Amanda CuddyDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Andrea P HempsteadDepartment of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Y Nancy YouDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Katherine Van LoonDepartment of Medicine, University of California San Francisco, San Francisco, California, USA.
Stefanos MillasDepartment of Surgery, The University of Texas Health Science Center, Houston, Texas, USA.
Jeffrey A MeyerhardtDana-Farber/Partners Cancer Care, Boston, Massachusetts, USA.
Patrick GavinPatient Advocate, Marne, Iowa, USA.
George J ChangDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
The University of Texas MD Anderson Cancer Center · USCancerCare · USPatient Advocate Foundation · USThe University of Texas Health Science Center at Houston · USUniversity of California, San Francisco · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
NCI NIH HHS P30 CA016672
6 · The paper itself

Abstract

objectiveWe sought to determine patients' informational needs for post-treatment surveillance and elicit clinicians' and patient advocates' (ie, stakeholders) opinions regarding what patients should know about post-treatment surveillance in the USA.

designA mixed-methods study, using semi-structured interviews followed by a survey study.

settingParticipants for the interviews were from two large academic medical centres and a safety-net hospital. The stakeholders were recruited from attendees at the Alliance for Clinical Trials in Oncology Network Spring 2016 meeting.

participantsParticipants for the in-depth interviews were purposively sampled. Eligible patients were 6 months to 5 years post curative resection for colorectal cancer and were fluent in English. Participants for the anonymous survey were stakeholders. MAIN OUTCOMES AND MEASURES: The main outcome was patients' with colorectal cancer informational needs for post-treatment surveillance, using an interview guide. The second outcome was the importance of the identified informational needs using an anonymous survey.

resultsOf the 67 patients approached, 31 were interviewed (response rate=46%), the majority were between 1 and 3 years post-treatment (81%) and diagnosed at stage III (74%). Despite a desire to monitor for cancer recurrence, patients had little understanding of the concept of post-treatment surveillance, equating surveillance with screening and a belief that if a recurrence was found early there would be a higher likelihood of cure. The survey suggested that clinicians (n=38) and patient advocates (n=11) had some differing opinions regarding what patients should know about surveillance to be active in decisions. For example, compared with clinicians, patient advocates felt that patients should know recurrence treatment options (100% vs 58%) and likelihood for cure following recurrence treatment (100% vs 38%).

conclusionsThe results of this exploratory mixed-methods study suggest that novel educational interventions targeting both patients and clinicians are needed to address the informational needs for post-treatment surveillance of colorectal cancer.

Indexed as

Attitude to HealthHealth Services Needs and DemandAgedColorectal NeoplasmsFemaleHumansInterviews as TopicMaleMiddle AgedNeoplasm Recurrence, LocalSurveys and QuestionnairesUnited Statescolorectal cancerhealth services researchmedical oncology clinical decision makingpatient preference

Identifiers

PMID31420381
PMCPMC6701633
OpenAlexW2968242298

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.